CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
Microenvironment plays a crucial role in tumor development and progression. Cancer cells modulate the tumor microenvironment, which also contribute to resistance to therapy. Identifying biomarkers involved in tumorigenesis and cancer progression represents a great challenge for cancer diagnosis and...
Main Authors: | Alexandra Landras, Coralie Reger de Moura, Fanelie Jouenne, Celeste Lebbe, Suzanne Menashi, Samia Mourah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/11/1803 |
Similar Items
-
EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
by: Lescaille Géraldine, et al.
Published: (2012-03-01) -
Differential CD147 Functional Epitopes on Distinct Leukocyte Subsets
by: Supansa Pata, et al.
Published: (2021-08-01) -
Spongionella secondary metabolites, promising modulators of immune response through CD147 receptor modulation
by: Jon Andoni Sánchez, et al.
Published: (2016-10-01) -
The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
by: Ye Y, et al.
Published: (2016-08-01) -
Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis
by: Jian-Jun Lv, et al.
Published: (2021-01-01)